Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 2.67 Billion | USD 4.24 Billion | 5.3% | 2023 |
According to a report from Zion Market Research, the global Softgel Capsules Market was valued at USD 2.67 Billion in 2023 and is projected to hit USD 4.24 Billion by 2032, with a compound annual growth rate (CAGR) of 5.3% during the forecast period 2024-2032.
This report explores market strengths, weakness, opportunities, and threats. It also provides valuable insights into the market's growth drivers, challenges, and the future prospects that may emerge in the Softgel Capsules Market industry over the next decade.
The report offers an assessment and analysis of the Softgel Capsules Market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD Billion).
Softgel capsule is a solid drug capsule that surrounds liquid center. Additionally, these products are oral dosages the same as capsules and are a combination of sorbitol, water, gelatin, and opacifier. The product can be included either in the outer gelatin capsule shell or inner soft gel capsule fill. Furthermore, the surge in the occurrence of chronic disorders is expected to create massive demand for soft gel capsules in the upcoming years. Moreover, these products have plethora of applications in healthcare and pharmaceutical sectors. They are also utilized as a medical supplement for heart disorders and antacids.
Softgel capsule is utilized for preventing vitamin deficiency arising due to poor diet and certain kinds of illness. In addition to this, it is easily soluble and can help in delivering ultra-low doses of low melting compound. Moreover, it generates less dust during production, thereby ensuring the safety of workers. Apart from this, the drug suspensions with unpleasant taste or odor can be ingested easily in the soft gel capsule as the latter provides convenient ingestion. All these aforementioned are anticipated to boost the growth of the soft gel capsules market.
Furthermore, soft gel capsules enhance melatonin bioavailability in human beings. Moreover, beneficial features of the product include solubility and tiny particle size. These products possess high dosage accuracy as well as uniformity stability. It can improve the bioavailability of poorly soluble medicines. Rise in consumer preference for the product due to its self-lubricating feature as well as its availability in myriad sizes, forms like chewable & meltable forms, and colors will aid the growth of the soft gel capsules market. Nonetheless, high product manufacturing costs and its susceptibility to getting affected in a humid or moist environment, as well as extreme temperatures, can pose threat to the growth of the industry in coming years.
Report Attributes | Report Details |
---|---|
Report Name | Softgel Capsules Market |
Market Size in 2023 | USD 2.67 Billion |
Market Forecast in 2032 | USD 4.24 Billion |
Growth Rate | CAGR of 5.3% |
Number of Pages | 186 |
Key Companies Covered | Catalent, Inc., Capsugel, Elnova Pharma, Hunan ER-KANG Pharmaceutical Co Ltd., Aenova Group GmbH, Guangdong Yichao Biological Co., Ltd., Sirio Pharma Company Ltd, Captek Softgel International Inc, Fuji Capsule Co., Ltd., EuroCaps Ltd., and KD Pharma Group |
Segments Covered | By Product, By End-User, By Application, And By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Europe To Lead Growth Of Softgel Capsules Market Over 2024-2032
The expansion of the soft gel capsules market in Europe over next seven years can be credited to large-scale funding of research activities pertaining to the manufacture of soft gel capsules in different European countries. Moreover, Gelatin has been recognized as GRAS (Generally Recognized As Safe) food ingredient by FDA and this has proved to be a key growth factor for the soft gel capsules market in Europe. An increase in product sales and the addition of new products to the existing product lines will chart a profitable growth path for the soft gel capsules industry in Europe over the years to come.
Key players lucratively impacting the growth of the soft gel capsules industry and profiled in the study is
By Product
By End-User
By Application
By Region
FrequentlyAsked Questions
Softgel capsule is utilized for preventing vitamin deficiency arising due to poor diet and certain kinds of illness. In addition to this, it is easily soluble and can help in delivering ultra-low doses of low melting compound. Moreover, it generates less dust during production, thereby ensuring safety of workers. Apart from this, the drug suspensions with unpleasant taste or odor can be ingested easily in the softgel capsule as the latter provides convenient ingestion. All these aforementioned are anticipated to boost growth of softgel capsules market.
Furthermore, softgel capsules enhance melatonin bioavailability in human beings. Moreover, beneficial features of the product include solubility and tiny particle size. These products possess high dosage accuracy as well as uniformity stability. It can improve bioavailability of poorly soluble medicines. Rise in consumer preference for the product due to its self-lubricating feature as well as its availability in myriad sizes, forms like chewable & meltable forms, and colors will aid growth of softgel capsules market.
Softgel Capsules Market size worth at USD 2.67 Billion in 2023 and projected to USD 4.24 Billion by 2032, with a CAGR of around 5.3% between 2024-2032.
Europe will contribute lucratively towards the regional market size over the estimated timeline. The regional market surge is subject to large-scale funding of research activities pertaining to manufacture of softgel capsules in different European countries. Moreover, Gelatin has been recognized as GRAS (Generally Recognized As Safe) food ingredient by FDA and this has proved to be a key growth factor for softgel capsules market in Europe. Increase in product sales and addition of new products to existing product line will chart a profitable growth path for softgel capsules industry in Europe over years to come.
The key market participants include Catalent, Inc., Capsugel, Elnova Pharma, Hunan ER-KANG Pharmaceutical Co Ltd., Aenova Group GmbH, Guangdong Yichao Biological Co., Ltd., Sirio Pharma Company Ltd, Captek Softgel International Inc, Fuji Capsule Co., Ltd., EuroCaps Ltd., and KD Pharma Group.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed